Alison Lawton

Alison Lawton

Director/Board Member bei DIANTHUS THERAPEUTICS, INC.

Vermögen: 71 817 $ am 31.03.2024

62 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Alison Francis Lawton is currently the Director at AgBiome INC, Independent Director at X4 Pharmaceuticals, Inc., Director at SwanBio Therapeutics, Inc., Independent Director at Dianthus Therapeutics, Inc., Independent Member-Supervisory Board at ProQR Therapeutics NV, and President at Cadena Bio, Inc. Previously, she served as the Chairman & President at Regulatory Affairs Professionals Society, Independent Director at Cubist Pharmaceuticals LLC, Director at CoLucid Pharmaceuticals, Inc., Independent Director at Spyre Therapeutics, Inc., Director at Follica, Inc., Director at Massachusetts Medical Device Industry Council, Independent Director at Verastem, Inc., Director at Kaleido Biosciences, Inc., Director at Magenta Therapeutics, Inc., Senior Vice President at Genzyme Corp., Chief Operating Officer at Aura Biosciences, Inc., Principal at Parke-Davis & Co. Ltd., General Manager at Genzyme Biosurgery Corp., General Manager-Biosurgery at Sanofi, Inc., Chief Operating Officer at OvaScience, Inc., Head-Genzyme Biosurgery at Sanofi-Aventis, Inc., Chief Operating Officer at X4 Pharmaceuticals, Inc., and Senior Vice President & General Manager at BIOSURGERY S.R.L.
She obtained her undergraduate degree from King's College London.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
13.06.2023 51 667 ( 0,03% ) 71 817 $ 31.03.2024
31.12.2023 0 ( -.--% ) - $ 31.03.2024
11.09.2023 0 ( -.--% ) - $ 31.03.2024

Aktive Positionen von Alison Lawton

UnternehmenPositionBeginn
PROQR THERAPEUTICS N.V. Director/Board Member 17.09.2014
X4 PHARMACEUTICALS, INC. Director/Board Member 05.10.2020
DIANTHUS THERAPEUTICS, INC. Director/Board Member 11.09.2023
President -
Director/Board Member 04.05.2021
Director/Board Member 19.01.2021
Alle aktiven Positionen von Alison Lawton

Ehemalige bekannte Positionen von Alison Lawton

UnternehmenPositionEnde
SPYRE THERAPEUTICS, INC. Director/Board Member 01.02.2024
KALEIDO BIOSCIENCES, INC. Chief Executive Officer 16.06.2020
VERASTEM, INC. Director/Board Member 19.05.2020
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Alison Lawton im Detail an

Ausbildung von Alison Lawton

King's College London Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Alison Lawton im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

24

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen7
AURA BIOSCIENCES, INC.

Health Technology

SPYRE THERAPEUTICS, INC.

Health Technology

VERASTEM, INC.

Health Technology

PROQR THERAPEUTICS N.V.

Health Technology

KALEIDO BIOSCIENCES, INC.

Health Technology

X4 PHARMACEUTICALS, INC.

Health Technology

DIANTHUS THERAPEUTICS, INC.

Health Technology

Private Unternehmen16

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Retail Trade

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

BIOSURGERY S.R.L.

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Alison Lawton